Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 1/20 | 0.32 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.32 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.32 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.32 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.30 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5899432 | 0.82 | TSHR (0.36) | ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL7409649 | 0.82 | — | — | |
| SCHEMBL22684752 | 0.81 | ENPP2 (0.33) | ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL4520012 | 0.79 | ENPP2 (0.32) | ENPP2ORAI1ORAI2ORAI3PDK1 | |
| SCHEMBL3426496 | 0.79 | ALDH1A1 (0.38) | ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL840950 | 0.79 | ENPP2 (0.32) | ENPP2ORAI1ORAI2ORAI3 | |
| SCHEMBL580069 | 0.79 | LIPG (0.33) | ENPP2 | |
| SCHEMBL3465794 | 0.78 | ENPP2 (0.56) | ENPP2ORAI1ORAI2ORAI3PDK1 | |
| SCHEMBL2704513 | 0.78 | TRIM24 (0.34) | — | |
| SCHEMBL16180703 | 0.77 | ENPP2 (0.39) | ENPP2ORAI1ORAI2ORAI3PDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118370856-A | Antibacterial and antioxidant composition and preparation method of diabetic ulcer dressing | 青岛大学 | 2024-07-23 | — | — | CN | disclosed |
| CN-118370856-A | Antibacterial and antioxidant composition and preparation method of diabetic ulcer dressing | 青岛大学 | 2024-07-23 | — | — | CN | disclosed |
| CN-116253755-A | Synthesis method of diaryl borate compound | 湖南大学 | 2023-06-13 | — | — | CN | disclosed |
| US-10014475-B2 | Graphene nanoribbons as semiconductors for organic thin film transistors | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2018-07-03 | — | — | US | disclosed |
| US-20160087212-A1 | GRAPHENE NANORIBBONS AS SEMICONDUCTORS FOR ORGANIC THIN FILM TRANSISTORS | CRESTLINE DIRECT FINANCE, L.P. | 2016-03-24 | — | — | US | disclosed |
| WO-2014171931-A1 | GRAPHENE NANORIBBONS AS SEMICONDUCTORS | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-10-23 | — | — | WO | disclosed |
| US-7038070-B2 | Preparation of preparing substituted indanones | BASELL POLYOLEFINE GMBH (DE) | 2006-05-02 | — | — | US | disclosed |
| US-6963017-B2 | Preparation of preparing substituted indanones | BASELL POLYOLEFINE GMBH (DE) | 2005-11-08 | — | — | US | disclosed |
| EP-0968158-B1 | METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM | BASELL POLYOLEFINE GMBH (DE) | 2005-08-10 | — | — | EP | disclosed |
| US-20050033076-A1 | Preparation of preparing substituted indanones | EQUISTAR CHEMICALS, LP | 2005-02-10 | — | — | US | disclosed |
| US-20030009046-A1 | Preparation of preparing substituted indanones | EQUISTAR CHEMICALS, LP | 2003-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10014475-B2 | Graphene nanoribbons as semiconductors for organic thin film transistors | STRA6, OR10J3, EPCAM | ENPP2 4235/4885ORAI1 4668/4885ORAI2 3103/4885 |
| US-20050033076-A1 | Preparation of preparing substituted indanones | CYP1A2, CYP2J2, IDH3A | ENPP2 4721/4885ORAI1 4605/4885ORAI2 1642/4885 |
| US-20160087212-A1 | GRAPHENE NANORIBBONS AS SEMICONDUCTORS FOR ORGANIC THIN FILM TRANSISTORS | STRA6, OR10J3, EPCAM | ENPP2 4235/4885ORAI1 4668/4885ORAI2 3103/4885 |
| US-20030009046-A1 | Preparation of preparing substituted indanones | CYP1A2, CYP1B1, CYP1A1 | ENPP2 4773/4885ORAI1 4577/4885ORAI2 1594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.